Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01962012 · ClinicalTrials.gov registry record · Phase 4

Effect of AcceleDent® Aura on Orthodontic Tooth Movement With Aligners

A Phase 4 study of Malocclusion, sponsored by OrthoAccel Technologies.

Completed
Registry status
Phase 4
Development phase
46
Enrollment target
1
Study location

NCT01962012: Completed Phase 4 study of Malocclusion, sponsored by OrthoAccel Technologies.

NCT01962012 is a Phase 4 study of Malocclusion that has completed, run by OrthoAccel Technologies. The registered enrollment target is 46 participants, below the 101-participant average among 6 other Malocclusion trials with a reported enrollment target (54% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01962012, a Phase 4 study of Malocclusion, has completed, sponsored by OrthoAccel Technologies.

COMPLETED
Registry status
Phase 4
Development phase
46 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to examine the amount of tooth movement achieved over time between subjects undergoing aligner treatment using a pulsation device known as AcceleDent® Aura with those not using the device.

Conditions Studied

Interventions

  • DEVICE Sham Device
  • DEVICE AcceleDent Aura

Study Locations (1)

Florida

  • University of Florida, Department of Orthodontics - Gainesville

Trial Details

FieldValue
Enrollment Target 46 participants
Start Date 2013-10
Est. Completion 2016-05
Phase Phase 4
OrthoAccel Technologies

2 total trials

What the finished NCT01962012 record still lists

NCT01962012 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 46 participants, a relatively small participant target, below the 101-participant average among 6 other Malocclusion trials with a reported enrollment target (54% lower).

The record links to 1 condition, with Malocclusion appearing as the primary indexed condition, and to 2 interventions - of which Sham Device is the first listed.

NCT01962012 reports a single indexed study location in Florida.

Frequently Asked Questions

What is clinical trial NCT01962012 about?

NCT01962012 is a clinical study titled "Effect of AcceleDent® Aura on Orthodontic Tooth Movement With Aligners". The purpose of this study is to examine the amount of tooth movement achieved over time between subjects undergoing aligner treatment using a pulsation device known as AcceleDent® Aura with those not using the device.

What is the current status of trial NCT01962012?

This trial is currently completed. It is a Phase 4 study. The enrollment target is 46 participants. The study started on 2013-10. Estimated completion is 2016-05.

What conditions does trial NCT01962012 study?

This clinical trial studies the following conditions: Malocclusion.

What interventions are being tested in trial NCT01962012?

The interventions under investigation include: Sham Device (DEVICE), AcceleDent Aura (DEVICE).

Who is sponsoring clinical trial NCT01962012?

This trial is sponsored by OrthoAccel Technologies, which has 2 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01962012 being conducted?

This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Malocclusion

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01890590 · 46 participants · NA

    A Phase II Study of Cyberknife Radiosurgery for Renal Cell Carcinoma

  • NCT03191149 · 46 participants · Phase 2

    Testing Osimertinib as a Treatment for Lung Cancers With an EGFR Exon 20 Change

  • NCT03510208 · 46 participants · Phase 1

    Panitumumab-IRDye800 in Diagnosing Participants With Malignant Glioma Undergoing Surgery

  • NCT04048278 · 46 participants · Early Phase 1

    Lidocaine Infusion in Pancreatic Cancer

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01962012, the US trial registry maintained by the National Library of Medicine. NCT01962012 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.